Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

H.J. Hammers; H.M.W. Verheul; B. Salumbides; R. Sharma; M. Rudek; J. Jaspers; P. Shah; L. Ellis; L. Shen; S. Paesante; K. Dykema; K. Furge; B. Teh; G. Netto; R. Pili

doi:https://doi.org/10.1158/1535-7163.MCT-09-1106

Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

H.J. Hammers, H.M.W. Verheul, B. Salumbides, R. Sharma, M. Rudek, J. Jaspers, P. Shah, L. Ellis, L. Shen, S. Paesante, K. Dykema, K. Furge, B. Teh, G. Netto, R. Pili

Medical oncology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

147 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1525-1535
Journal	Molecular Cancer Therapeutics
Volume	9
Issue number	6
DOIs	https://doi.org/10.1158/1535-7163.MCT-09-1106
Publication status	Published - 2010

Access to Document

https://doi.org/10.1158/1535-7163.MCT-09-1106

Cite this

Hammers, H. J., Verheul, H. M. W., Salumbides, B., Sharma, R., Rudek, M., Jaspers, J., Shah, P., Ellis, L., Shen, L., Paesante, S., Dykema, K., Furge, K., Teh, B., Netto, G., & Pili, R. (2010). Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study. Molecular Cancer Therapeutics, 9(6), 1525-1535. https://doi.org/10.1158/1535-7163.MCT-09-1106

@article{12a0236e436144b98d3df7040f29a396,

title = "Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study",

author = "H.J. Hammers and H.M.W. Verheul and B. Salumbides and R. Sharma and M. Rudek and J. Jaspers and P. Shah and L. Ellis and L. Shen and S. Paesante and K. Dykema and K. Furge and B. Teh and G. Netto and R. Pili",

year = "2010",

doi = "https://doi.org/10.1158/1535-7163.MCT-09-1106",

language = "Undefined/Unknown",

volume = "9",

pages = "1525--1535",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

Hammers, HJ, Verheul, HMW, Salumbides, B, Sharma, R, Rudek, M, Jaspers, J, Shah, P, Ellis, L, Shen, L, Paesante, S, Dykema, K, Furge, K, Teh, B, Netto, G & Pili, R 2010, 'Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study', Molecular Cancer Therapeutics, vol. 9, no. 6, pp. 1525-1535. https://doi.org/10.1158/1535-7163.MCT-09-1106

TY - JOUR

T1 - Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

AU - Hammers, H.J.

AU - Verheul, H.M.W.

AU - Salumbides, B.

AU - Sharma, R.

AU - Rudek, M.

AU - Jaspers, J.

AU - Shah, P.

AU - Ellis, L.

AU - Shen, L.

AU - Paesante, S.

AU - Dykema, K.

AU - Furge, K.

AU - Teh, B.

AU - Netto, G.

AU - Pili, R.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1158/1535-7163.MCT-09-1106

DO - https://doi.org/10.1158/1535-7163.MCT-09-1106

M3 - Article

C2 - 20501804

SN - 1535-7163

VL - 9

SP - 1525

EP - 1535

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 6

ER -